Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Alain

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
La Revue Du Praticien|April 16, 2019
[Cytomegalovirus infections]Sébastien Hantz, Sophie Alain
Joint Bone Spine|April 2, 2017
Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritisMarc Scherlinger, Sophie Alain, Christophe Richez
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 1, 2023
Evaluation of the fully automated LIAISON®XL chemiluminescence analyzer for QuantiFERON®-CMV testing in transplant recipientsSarah Mafi, Sophie Alain, Sébastien Hantz
Virologie (Montrouge, France)|September 24, 2022
[cytomegalovirus; resistance; antiviral therapy; UL97 kinase; polymerase]Sophie Alain, Sébastien Cotin, Sébastien Hantz
Presse Medicale (Paris, France : 1983)|July 20, 2005
[Anti-papillomavirus vaccines and prevention of cervical cancer: progress and prospects]Sébastien Hantz, Sophie Alain, François Denis
Vaccines|September 28, 2021
Towards a Prophylactic Vaccine for the Prevention of HCMV InfectionGaëtan Ligat, Sophie Alain, Sébastien Hantz
Antiviral Research|July 21, 2023
Identification of a leucine-zipper motif in pUL51 essential for HCMV replication and potential target for antiviral developmentClotilde Muller, Sophie Alain, Sébastien Hantz
Virologie (Montrouge, France)|September 24, 2022
[Therapeutic HPV vaccines]Sébastien Hantz, Sophie Alain, François Denis
Frontiers in Microbiology|December 6, 2023
Anti-CMV therapy, what next? A systematic reviewClaire Gourin, Sophie Alain, Sébastien Hantz
Medecine Sciences : M/S|April 17, 2007
[New routes of administration: epidermal, transcutaneous mucosal ways of vaccination]François Denis, Sophie Alain, Marie-Cécile Ploy
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
La Revue Du Praticien|April 16, 2019
[Cytomegalovirus infections]Sébastien Hantz, Sophie Alain
Joint Bone Spine|April 2, 2017
Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritisMarc Scherlinger, Sophie Alain, Christophe Richez
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 1, 2023
Evaluation of the fully automated LIAISON®XL chemiluminescence analyzer for QuantiFERON®-CMV testing in transplant recipientsSarah Mafi, Sophie Alain, Sébastien Hantz
Virologie (Montrouge, France)|September 24, 2022
[cytomegalovirus; resistance; antiviral therapy; UL97 kinase; polymerase]Sophie Alain, Sébastien Cotin, Sébastien Hantz
Presse Medicale (Paris, France : 1983)|July 20, 2005
[Anti-papillomavirus vaccines and prevention of cervical cancer: progress and prospects]Sébastien Hantz, Sophie Alain, François Denis
Vaccines|September 28, 2021
Towards a Prophylactic Vaccine for the Prevention of HCMV InfectionGaëtan Ligat, Sophie Alain, Sébastien Hantz
Antiviral Research|July 21, 2023
Identification of a leucine-zipper motif in pUL51 essential for HCMV replication and potential target for antiviral developmentClotilde Muller, Sophie Alain, Sébastien Hantz
Virologie (Montrouge, France)|September 24, 2022
[Therapeutic HPV vaccines]Sébastien Hantz, Sophie Alain, François Denis
Frontiers in Microbiology|December 6, 2023
Anti-CMV therapy, what next? A systematic reviewClaire Gourin, Sophie Alain, Sébastien Hantz
Medecine Sciences : M/S|April 17, 2007
[New routes of administration: epidermal, transcutaneous mucosal ways of vaccination]François Denis, Sophie Alain, Marie-Cécile Ploy
Pageof 13